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ABSTRACT
Background: A new method for determining
serum specific IgE (IMMULITE“ 2000 3gAllergy) has
recently become available.
Objective: To evaluate the clinical performance of
IMMULITE 2000 in the diagnosis of cow’s milk aller-
gy compared with that of UniCAP“. Additionally, we
verified the behavior of both methods at two diag-
nostic decision points proposed by other authors.
Methods: The study population consisted of 31
children with cow’s milk allergy (group A) and a con-
trol group of 19 atopic children without food allergy
(group B). A blood sample from each child was tested
using both methods and the results were compared.
Results: In group A, the values for cow’s milk IgE
ranged from 0.35 kU/L (the lowest common detec-
tion limit) to above 100 kU/L. In group B, the values
were less than 1.1 kU/L for IMMULITE 2000 and less
than 1.6 kU/L for UniCAP. An agreement of 90 % in
IgE classes was obtained. Both methods demon-
strated exactly the same diagnostic performance
(sensitivity: 100 %; specificity: 78.9 %; negative pre-
dictive value: 100%; positive predictive value: 84.6%;
efficiency: 90.2 %). The evaluation of the two meth-
ods at the two different decision points proposed in
the literature showed a better positive predictive val-
ue with UniCAP, but we obtained equivalent perfor-
mance with IMMULITE 2000 by choosing higher cut-
off values.
Conclusions: We conclude that IMMULITE 2000 is
as effective as UniCAP in the diagnosis of cow’s milk
allergy. Both methods can be used to obtain site-spe-
cific decision points that are population, age and dis-
ease dependent.
Keywords: Cow’s milk allergy; food hypersensitivity;
immunoassay; infant food; milk proteins; predictive
value; specific IgE; IMMULITE“ 2000 3gAllergy; Uni-
CAP“
Cow’s milk allergy (CMA) occurs mainly during the
first years of life and is one of the most prevalent
food allergies in many countries. In our country it is
by far the most common food allergy in children. An
accurate diagnosis is necessary in order to protect
children from either inadequate or unnecessary
avoidance diets. This usually requires the perfor-
mance of oral food challenges, exposing the patient
to the risk of a severe allergic reaction. Moreover,
food challenges are time consuming procedures, es-
pecially when they are performed in double blind
controlled protocols1,2.
Methods for determination of serum allergen spe-
cific IgE (sIgE) have been improved over the past
years and the possibility of quantitative determina-
tion of food specific IgE opened new perspectives on
the diagnosis and follow-up of these patients. Spe-
cific IgE decision points with a high predictive level of
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clinical reactivity to foods like milk, egg, fish and
peanut have been established3-5. However, the deci-
sion points obtained for the same allergens are con-
siderably different, presumably depending on the
characteristics of the population studied, such as age
and type of clinical manifestations6. The method
used by these groups was the same – UniCAP“
(Pharmacia, Uppsala, Sweden).
A new method for sIgE, IMMULITE“ 2000 3gAller-
gy (Diagnostic Products Corporation, Los Angeles,
USA) has been introduced recently7,8. In this study,
we evaluated the clinical performance of IMMULITE
2000 with respect to detection of cow’s milk allergy
by comparing it with UniCAP and by verifying, within
our population, the behavior of both methods, at two
different decision points (cutoffs) as previously pro-
posed by other authors3,4.
METHODS
Patients
Among the children on follow-up at our outpatient
unit for CMA we selected those with indication to
be submitted to a follow-up challenge, according to
the clinical criteria in use at our department (table I).
We included 31 patients (17 males, 14 females) aged
between 1 and 9 years old (median: 3,5 years) -
group A. All cases presented with immediate type re-
actions—urticaria, angioedema, vomiting or bron-
chospasm—and all had positive reactions to skin
prick tests for whole milk and/or protein fractions
(from IPI-ASAC Spain: milk, casein, alpha-lactoalbu-
min and beta-lactoglobulin). The diagnosis in each
had been previously confirmed by positive food chal-
lenges.
For the control group (group B), we selected chil-
dren with atopic dermatitis because this is a situation
where it is common to find low levels of food specific
IgE, even in patients without food allergy. In this
group we included 19 children (10 males, 9 females)
aged between 2 and 14 years old (median: 5,0 years),
without clinical evidence of CMA, followed by us for
other allergic diseases (atopic dermatitis in 19, asth-
ma in 9, rhinitis in 9). The atopic dermatitis was mild
and intermitent in all cases, with symptom free peri-
ods despite a daily regular intake of dairy products.
Cow’s milk oral challenges
During the study all patients underwent reevalua-
tion, which included an oral milk-challenge test. In-
formed consent was obtained from the parents, ac-
cording to the recomendations of the hospital ethics
committee. Given the young age of the children and
because we expected immediate and objective reac-
tions, we decided to use an open protocol. All chal-
lenges were performed under medical surveillance at
the day-hospital unit, with appropriate medication
and resuscitation equipment available. Increasing
doses of cow’s milk infant formula (1, 5, 10, 20, 40,
80 ml with a repeat dose of 80 ml, to a cumulative
dose of 236 ml) were given at 30-minute intervals.
The challenge was discontinued and considered to
be positive if a clinical reaction appeared (urticaria,
angioedema, erythematous rash, vomiting, diarrhea,
bronchospasm, rhinoconjunctivitis or hypotension). In
instances of a clinical reaction, treatment was provid-
ed according to the type and severity of symptoms.
After the challenge, the child remained under obser-
vation for at least six hours. If the challenge was neg-
ative, dairy products were freely introduced to the
child’s diet and a new visit was scheduled within a
week to check for the development of late symp-
toms.
Children from the control group were not chal-
lenged since they were regularly consuming dairy
products without evidence of an adverse impact on
their allergic disease.
In vitro tests
A blood sample was obtained from each child
close to the challenge test—within approximately
one month. Each blood sample was tested for cow’s
milk specific IgE using the IMMULITE 2000“ and the
UniCAP“.
IMMULITE 2000 is a third generation sIgE two-
step chemiluminescent enzyme immunoassay which
uses a solid phase (bead). Both the IMMULITE 2000
and UniCAP assays were performed according to the
manufacturer’s instructions. The results were consid-
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Table I
Clinical criteria for the performance of follow-up 
cow’s milk challenge in children with cow’s milk allergy
∑ First follow-up challenge:
– Between 12 and 18 months of age
∑ Subsequent challenges:
– 12 months after the last positive challenge 
(or accidental reaction) for children until 3 years of age
– 24 months after the last positive challenge (or accidental
reaction) for children between 3 and 6 years of age
– 36 months after the last positive challenge (or accidental
reaction) for children older than 6 years
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ered positive when a level of, at least, 0.35 kU/L was
obtained.
RESULTS
During the study, all children in patient group A
were rechallenged to assess their state of tolerance.
Of 31 milk challenges, 22 were positive (current
CMA) and 9 were negative (past CMA). Samples for
sIgE analysis were taken from all 50 children, (current
CMA, past CMA and controls).
The values obtained for milk specific IgE in patient
group A ranged from the detection limit of 0.35 kU/L,
to the upper limit of 100 kU/L with UniCAP“ and from
below the IMMULITE“ 2000 detection limit of 0.15 to
the upper limit of 100 kU/L. Two patients had nega-
tive results (< 0,35 kU/L) with IMMULITE 2000 and
three with UniCAP. In the control group B, the values
were under 1.1 kU/L for IMMULITE 2000 and under
1.6 kU/L for UniCAP. Four patients had low positive
results with both methods.
Any value at or below the detection limit of
0.35 kU/L, or at or above the upper limit of 100 kU/L
for either assay, was considered to be out of range.
Using these criteria, just 20 of the 50 paired samples
fell within the common 0.35 to100 kU/L range by
both in vitro assays. Working in a logarithmic scale,
we compared the results for the 20 in-range sam-
ples, noting a trend towards reporting higher concen-
trations of sIgE by the IMMULITE 2000 assay in
most patients (fig. 1).
We evaluated the agreement between methods in
terms of sIgE class (table II). In this case, as the
analysis is qualitative, not quantitative, we used data
from all 50 children. Considering a class 0 result as
negative and classes 1 through 6 as positive, we ob-
tained 90 % agreement with only five discordant re-
sults. One of these five belonged to group A and was
positive (class 1) according to the IMMULITE 2000
assay, but negative using UniCAP. The challenge test
for this patient was negative, indicating that he had
achieved clinical remission. The additional four discor-
dant cases were from group B. Two were falsely pos-
itive according to UniCAP (class 1) and the other two,
using the IMMULITE 2000 (class 2).
We observed good agreement between methods
in the lower classes, with results concurring either
within the same class or within one class difference.
We observed higher results with IMMULITE 2000 in
the upper classes; specifically six patients designat-
ed as class 6 according to IMMULITE 2000 were
designated as class 4 using UniCAP (all were positive
by challenge test).
To calculate the diagnostic performance of the
methods, we included only the 22 patients with ac-
tive disease (positive challenge) and the 19 controls.
Samples were considered positive if values were
above 0.35 kU/L by either method and were compa-
red with the results of the food challenge test. In this
sample of 41 patients (CMA prevalence = 53.6 %),
both methods demonstrated the same performance:
100 % sensitivity; 78.9 % specificity; 100 % negative
predictive value; 84.6 % positive predictive value;
90.2 % efficiency.
We also evaluated the behavior of both methods
at two different decision points previously proposed
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Figure 1.—Cow’s milk specific IgE – comparison between me-
thods for the 20 in-range samples (results within 0.35 and
100 kU/L).
100,00
10,00
1,00
0,10
Immulite UniCAP
kU
/L
Table II
Comparison between methods according to sIgE class
(90 % agreement)
UniCAP
Class 0 1 2 3 4 5 6
0 15 2
1 1 2
2 2 5 2
3 2 1
4 5 2
5 1
6 6 3 1
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in the literature (Sampson et al3, Garcia-Ara et al4).
The results also showed a distribution with a fairly
clear trend encompassing both of the cutoffs pro-
posed for the Pharmacia system. We applied vari-
ous symmetric (invertible) regression analyses to
the data, using them to predict equivalent cutoffs
for the DPC system. Corresponding to the proposed
levels of 2.5 and 15 kU/L for UniCAP, the regression
analyses predicted the following levels for IM-
MULITE 2000: 3.5 and 25 kU/L by Deming (fig. 2);
3.6 and 33 kU/L by OLS Bisector (not shown);
5.6 and 44 kU/L by Passing-Bablok (not shown).
In order to verify how well the two methods dis-
criminated between children with current and past
CMA, we included only those patients in group A
within our analysis (table III). At the cutoff decision
point of 15 kU/L (as proposed by Sampson3 for milk
reactivity) we observed that, in our population, Uni-
CAP shows a slightly better positive predictive value
(100 %) than IMMULITE 2000 (95 %), although Uni-
CAP’s sensitivity was much lower than IMMULITE’s
at this cutoff (64 % vs. 86 %, respectively). However,
we verified that we could obtain exactly the same
positive predictive value (100 %) with IMMULITE
2000 by choosing a higher cutoff point of 35 kU/L, al-
beit at the cost of sensitivity (64 %). Similarly, at the
much lower cutoff of 2.5 kU/L proposed by Garcia-
Ara4, UniCAP shows a somewhat better positive pre-
dictive value than IMMULITE 2000 (95.2 % vs.
84.0%) but once again with lower sensitivity (90.9%
UniCAP vs. 95.4% IMMULITE 2000). However, table II
demonstrates that the performance and sensitivity of
IMMULITE 2000 exactly equals UniCAP’s perfor-
mance if we increase the cutoff to 5 kU/L.
DISCUSSION
In our study population, IMMULITE“ 2000 de-
monstrated reliable results in the detection of cow’s
milk specific IgE and its performance was found to
be comparable to that of UniCAP“. IMMULITE 2000
demonstrated a tendency to report results for sIgE at
greater concentrations, which was more evident in
the higher range of results. However, at the usual
positive cutoff of 0.35 kU/L, both methods detected
all cases of CMA (100 % sensitivity). The specificity
was also equal for the two methods and, although
somewhat lower (78.9 %), it was acceptable, con-
sidering the particular characteristics of the control
group. For this group, we deliberately chose children
with atopic dermatitis because this is a clinical situa-
tion where we often find high levels of serum IgE,
increasing the likelihood of false positive sIgE results.
With this kind of control group, we found the speci-
ficity of the IMMULITE 2000 method was as good as
the UniCAP.
The methods of diagnosing IgE mediated food al-
lergy, either by skin prick tests or by assaying for
serum sIgE, are usually very sensitive but less specif-
ic, demanding confirmation of the results by means
of oral challenge tests1. This has led several groups to
try to determine the decision point levels of sIgE with
a higher positive predictive value for clinical reac-
tivity3-5. In a study involving a sample of children with
atopic dermatitis, Sampson et al9 proposed an opti-
mal decision point of 32 kU/L for cow’s milk allergy. In
this population at this decision point level, the test
showed a positive predictive value of 95 %, a sensi-
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Figure 2.—Prediction of cutoffs for the IMMULITE“ 2000 3gAller-
gy corresponding to published cutoffs for UniCAP“ as determined
by Deming symmetric regression analyse.
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Table III
Comparison between methods at different cutoffs
Cutoff Method Sensitivity Specificity NPV PPV
2,5 kU/L IMMULITE 2000 95.4 55.6 83.3 84.0
UniCAP 90.9 88.9 80.0 95.2
5 kU/L IMMULITE 2000 90.9 88.9 80.0 95.2
UniCAP 86.4 88.9 72.7 95.0
15 kU/L IMMULITE 2000 86.4 88.9 72.7 95.0
UniCAP 63.6 100.0 52.9 100.0
35 kU/L IMMULITE 2000 63.6 100.0 52.9 100.0
UniCAP 36.4 100.0 39.1 100.0
NPV: negative predictive value; PPV: positive predictive value.
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tivity of 51% and specificity of 98%. In a subsequent
work by the same group, this decision point was ap-
plied to another population of children referred for
evaluation of food allergy, where only 61% had atopic
dermatitis. In this clinically different population, the
sensitivity of the test decreased to 34 % and a better
performance was obtained by using a lower decision
point of 15 kU/L (57 % sensitivity, 94 % specificity). In
a recent prospective study of a group of children with
cow’s milk allergy, Garcia-Ara et al10 showed that the
sIgE levels, which were predictors of clinical reactivi-
ty, increased with age. This suggests that age must
also be taken into consideration when establishing
sIgE cutoffs. All these data strongly suggest that the
decision point levels of sIgE predictive of clinical reac-
tivity are population specific6.
It was not our intention to establish our own cutoff
points in this study because our study population was
not large enough; rather, we were interested in com-
paring the behavior of the two methods at the cutoffs
established by other authors. We focused on two dif-
ferent decision points, both obtained using the Uni-
CAP, in two different populations. The decision point
proposed by Sampson (15 kU/L) was obtained in a
population of older children, most of whom present-
ed with atopic dermatitis.3 The other, proposed by
Garcia-Ara et al, was somewhat lower (2.5 kU/L), and
was obtained in a population of infants with immedi-
ate-type symptoms4. The different characteristics of
the two populations could explain the different cutoffs
obtained by the two groups.
In our study, we obtained the same performance
with both methods by using different cutoff levels.
Accordingly, the decision points seem also to be spe-
cific to the method. The main consequence is that
the results obtained by the two methods should not
be used interchangeably, since the same result could
have a different meaning, depending on the method
by which it was obtained.
Our study has shown IMMULITE 2000 3gAllergy
to be a reliable method for detecting cow’s milk aller-
gy and as adequate as UniCAP in the diagnosis of
CMA. Since decision levels of sIgE can depend on
population, age, allergens, diseases and in vitro meth-
ods, each clinic must define the allergen cutoff for
their own population. Care must be taken in avoiding
a generalization of the use of the published cutoffs.
The comparable clinical performance for milk allergy
reported in this study indicated that either of the two
methods can be used to obtain the population, age,
disease and site-specific decision cutoff levels.
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